BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nicastri E, Petrosillo N, Ascoli Bartoli T, Lepore L, Mondi A, Palmieri F, D'Offizi G, Marchioni L, Murachelli S, Ippolito G, Antinori A. National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep 2020;12:8543. [PMID: 32218915 DOI: 10.4081/idr.2020.8543] [Cited by in Crossref: 96] [Cited by in F6Publishing: 79] [Article Influence: 48.0] [Reference Citation Analysis]
Number Citing Articles
1 Vistoli F, Furian L, Maggiore U, Caldara R, Cantaluppi V, Ferraresso M, Zaza G, Cardillo M, Biancofiore G, Menichetti F, Russo A, Turillazzi E, Di Paolo M, Grandaliano G, Boggi U; Italian National Kidney Transplantation Network., the Joint Committee of the Italian Society of Organ Transplantation and the Italian Society of Nephrology. COVID-19 and kidney transplantation: an Italian Survey and Consensus. J Nephrol 2020;33:667-80. [PMID: 32495231 DOI: 10.1007/s40620-020-00755-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
2 Colafrancesco S, Scrivo R, Barbati C, Conti F, Priori R. Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients. Front Immunol 2020;11:1439. [PMID: 32655577 DOI: 10.3389/fimmu.2020.01439] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
3 Bian Y, Le Y, Du H, Chen J, Zhang P, He Z, Wang Y, Yu S, Fang Y, Yu G, Ling J, Feng Y, Wei S, Huang J, Xiao L, Zheng Y, Yu Z, Li S. Efficacy and Safety of Anticoagulation Treatment in COVID-19 Patient Subgroups Identified by Clinical-Based Stratification and Unsupervised Machine Learning: A Matched Cohort Study. Front Med (Lausanne) 2021;8:786414. [PMID: 35004751 DOI: 10.3389/fmed.2021.786414] [Reference Citation Analysis]
4 Seo MR, Kim J, Park E, Jung SM, Sung Y, Kim H, Kim G, Kim H, Lee M, Lee J, Hur J, Chin BS, Eom JS, Baek HJ; The Korean College of Rheumatology Working Group. Recommendations for the Management of Patients With Systemic Rheumatic Diseases During the Coronavirus Disease Pandemic. J Rheum Dis 2020;27:218-32. [DOI: 10.4078/jrd.2020.27.4.218] [Reference Citation Analysis]
5 Monedero P, Gea A, Castro P, Candela-Toha AM, Hernández-Sanz ML, Arruti E, Villar J, Ferrando C; COVID-19 Spanish ICU Network. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Crit Care 2021;25:2. [PMID: 33397463 DOI: 10.1186/s13054-020-03422-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
6 Abayomi A, Osibogun A, Ezechi O, Wright K, Ola B, Ojo O, Kuyinu Y, Zamba E, Abdur-Razzaq H, Erinoso OA, Anya SE. A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial. Trials 2021;22:869. [PMID: 34863267 DOI: 10.1186/s13063-021-05675-x] [Reference Citation Analysis]
7 Fong D, Rauch S, Petter C, Haspinger E, Alber M, Mitterer M. Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy. ESMO Open 2020;5:e000810. [PMID: 32527730 DOI: 10.1136/esmoopen-2020-000810] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
8 Micallef S, Piscopo TV, Casha R, Borg D, Vella C, Zammit MA, Borg J, Mallia D, Farrugia J, Vella SM, Xerri T, Portelli A, Fenech M, Fsadni C, Mallia Azzopardi C. The first wave of COVID-19 in Malta; a national cross-sectional study. PLoS One 2020;15:e0239389. [PMID: 33057434 DOI: 10.1371/journal.pone.0239389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Petrone L, Petruccioli E, Alonzi T, Vanini V, Cuzzi G, Najafi Fard S, Castilletti C, Palmieri F, Gualano G, Vittozzi P, Nicastri E, Lepore L, Grifoni A, Antinori A, Vergori A, Ippolito G, Cantini F, Goletti D. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect 2021;82:58-66. [PMID: 33639176 DOI: 10.1016/j.jinf.2021.02.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
10 Oscanoa TJ, Romero-Ortuno R, Carvajal A, Savarino A. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus? Int J Antimicrob Agents 2020;56:106078. [PMID: 32629115 DOI: 10.1016/j.ijantimicag.2020.106078] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
11 Micarelli A, Granito I, Carlino P, Micarelli B, Alessandrini M. Self-perceived general and ear-nose-throat symptoms related to the COVID-19 outbreak: a survey study during quarantine in Italy. J Int Med Res 2020;48:300060520961276. [PMID: 33081538 DOI: 10.1177/0300060520961276] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
12 Chivese T, Musa OAH, Hindy G, Al-Wattary N, Badran S, Soliman N, Aboughalia ATM, Matizanadzo JT, Emara MM, Thalib L, Doi SAR. Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis. Travel Med Infect Dis 2021;43:102135. [PMID: 34265436 DOI: 10.1016/j.tmaid.2021.102135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sheikhpour M. The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19). Ther Clin Risk Manag 2020;16:933-46. [PMID: 33116543 DOI: 10.2147/TCRM.S262936] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Petruccioli E, Najafi Fard S, Navarra A, Petrone L, Vanini V, Cuzzi G, Gualano G, Pierelli L, Bertoletti A, Nicastri E, Palmieri F, Ippolito G, Goletti D. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. J Transl Med 2021;19:272. [PMID: 34174875 DOI: 10.1186/s12967-021-02938-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci 2020;41:1667-71. [PMID: 32483687 DOI: 10.1007/s10072-020-04486-3] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 35.0] [Reference Citation Analysis]
16 Casati M, Intra J, Rossi W, Giacobone C, Brivio R. Hemolysis and blood gas analysis: it’s time for a change! Scandinavian Journal of Clinical and Laboratory Investigation. [DOI: 10.1080/00365513.2022.2034037] [Reference Citation Analysis]
17 Georgiev T. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs. Rheumatol Int. 2020;40:825-826. [PMID: 32232552 DOI: 10.1007/s00296-020-04570-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
18 Giannitto C, Sposta FM, Repici A, Vatteroni G, Casiraghi E, Casari E, Ferraroli GM, Fugazza A, Sandri MT, Chiti A, Luca B. Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab. Radiol Med 2020;125:1260-70. [PMID: 32862406 DOI: 10.1007/s11547-020-01269-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
19 Wang Z, Wang Y, Yang Z, Wu H, Liang J, Liang H, Lin H, Chen R, Ou Y, Wang F, Wang Y, Wang Y, Luo W, Li N, Li Z, Xie J, Jiang M, Li S. The use of non-invasive ventilation in COVID-19: A systematic review. Int J Infect Dis 2021;106:254-61. [PMID: 33798720 DOI: 10.1016/j.ijid.2021.03.078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Saghir SAM, AlGabri NA, Alagawany MM, Attia YA, Alyileili SR, Elnesr SS, Shafi ME, Al-Shargi OYA, Al-Balagi N, Alwajeeh AS, Alsalahi OSA, Patra AK, Khafaga AF, Negida A, Noreldin A, Al-Amarat W, Almaiman AA, El-Tarabily KA, Abd El-Hack ME. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review. Ther Clin Risk Manag 2021;17:371-87. [PMID: 33953559 DOI: 10.2147/TCRM.S301817] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
21 Inchingolo AD, Inchingolo AM, Bordea IR, Malcangi G, Xhajanka E, Scarano A, Lorusso F, Farronato M, Tartaglia GM, Isacco CG, Marinelli G, D'Oria MT, Hazballa D, Santacroce L, Ballini A, Contaldo M, Inchingolo F, Dipalma G. SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms 2021;9:525. [PMID: 33806624 DOI: 10.3390/microorganisms9030525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
22 Bassetti M, Giacobbe DR, Aliberti S, Barisione E, Centanni S, De Rosa FG, Di Marco F, Gori A, Granata G, Mikulska M, Petrosillo N, Richeldi L, Santus P, Tascini C, Vena A, Viale P, Blasi F; Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect 2020;26:880-94. [PMID: 32360444 DOI: 10.1016/j.cmi.2020.04.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
23 Singh TU, Parida S, Lingaraju MC, Kesavan M, Kumar D, Singh RK. Drug repurposing approach to fight COVID-19. Pharmacol Rep 2020;72:1479-508. [PMID: 32889701 DOI: 10.1007/s43440-020-00155-6] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 43.5] [Reference Citation Analysis]
24 AlShoaibi NA, Maghrabi K, Alanazi H, Harbi MA, Alghamdi S. Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19. Ann Saudi Med 2020;40:365-72. [PMID: 32954790 DOI: 10.5144/0256-4947.2020.365] [Reference Citation Analysis]
25 Ghale-Noie ZN, Salmaninejad A, Bergquist R, Mollazadeh S, Hoseini B, Sahebkar A. Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement. Adv Exp Med Biol 2021;1327:3-22. [PMID: 34279825 DOI: 10.1007/978-3-030-71697-4_1] [Reference Citation Analysis]
26 Parchure P, Joshi H, Dharmarajan K, Freeman R, Reich DL, Mazumdar M, Timsina P, Kia A. Development and validation of a machine learning-based prediction model for near-term in-hospital mortality among patients with COVID-19. BMJ Support Palliat Care 2020:bmjspcare-2020-002602. [PMID: 32963059 DOI: 10.1136/bmjspcare-2020-002602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
27 [DOI: 10.1101/2020.06.17.20134031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Kalra MK, Homayounieh F, Arru C, Holmberg O, Vassileva J. Chest CT practice and protocols for COVID-19 from radiation dose management perspective. Eur Radiol. 2020;30:6554-6560. [PMID: 32621238 DOI: 10.1007/s00330-020-07034-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
29 Colafrancesco S, Alessandri C, Conti F, Priori R. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Autoimmun Rev. 2020;19:102573. [PMID: 32387470 DOI: 10.1016/j.autrev.2020.102573] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 48.0] [Reference Citation Analysis]
30 Thevarajan I, Buising KL, Cowie BC. Clinical presentation and management of COVID-19. Med J Aust 2020;213:134-9. [PMID: 32677734 DOI: 10.5694/mja2.50698] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
31 Petrone L, Petruccioli E, Vanini V, Cuzzi G, Najafi Fard S, Alonzi T, Castilletti C, Palmieri F, Gualano G, Vittozzi P, Nicastri E, Lepore L, Antinori A, Vergori A, Caccamo N, Cantini F, Girardi E, Ippolito G, Grifoni A, Goletti D. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect 2021;27:286.e7-286.e13. [PMID: 33045370 DOI: 10.1016/j.cmi.2020.09.051] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
32 Cheng FY, Joshi H, Tandon P, Freeman R, Reich DL, Mazumdar M, Kohli-Seth R, Levin M, Timsina P, Kia A. Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients. J Clin Med 2020;9:E1668. [PMID: 32492874 DOI: 10.3390/jcm9061668] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 22.5] [Reference Citation Analysis]
33 Seo MR, Kim JW, Park EJ, Jung SM, Sung YK, Kim H, Kim G, Kim HS, Lee MS, Lee J, Hur JA, Chin BS, Eom JS, Baek HJ; Korean College of Rheumatology working group. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic. Korean J Intern Med 2020;35:1317-32. [PMID: 32972125 DOI: 10.3904/kjim.2020.417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Aiello A, Najafi Fard S, Petruccioli E, Petrone L, Vanini V, Farroni C, Cuzzi G, Navarra A, Gualano G, Mosti S, Pierelli L, Nicastri E, Goletti D. Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients. Int J Infect Dis 2021;106:338-47. [PMID: 33864921 DOI: 10.1016/j.ijid.2021.04.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
35 Farroni C, Picchianti-diamanti A, Aiello A, Nicastri E, Laganà B, Agrati C, Castilletti C, Meschi S, Colavita F, Cuzzi G, Casetti R, Grassi G, Petrone L, Vanini V, Salmi A, Repele F, Altera AMG, Maffongelli G, Corpolongo A, Salemi S, Di Rosa R, Nalli G, Sesti G, Vaia F, Puro V, Goletti D. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis. Front Immunol 2022;13:846753. [DOI: 10.3389/fimmu.2022.846753] [Reference Citation Analysis]
36 Kory P, Meduri GU, Iglesias J, Varon J, Marik PE. Clinical and Scientific Rationale for the "MATH+" Hospital Treatment Protocol for COVID-19. J Intensive Care Med 2021;36:135-56. [PMID: 33317385 DOI: 10.1177/0885066620973585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
37 Boretti A. Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection. Journal of Trace Elements in Medicine and Biology 2022;71:126954. [DOI: 10.1016/j.jtemb.2022.126954] [Reference Citation Analysis]
38 Farag EA, Islam MM, Enan K, El-Hussein AM, Bansal D, Haroun M. SARS-CoV-2 at the human-animal interphase: A review. Heliyon 2021;7:e08496. [PMID: 34869934 DOI: 10.1016/j.heliyon.2021.e08496] [Reference Citation Analysis]
39 Shahmohamadnejad S, Nabavi SF, Habtemariam S, Sarkar K, Sil PC, Dowran R, Nabavi SM. May we target double-membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection? Cell Biol Int 2020;44:1770-2. [PMID: 32449802 DOI: 10.1002/cbin.11400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
40 Joshi G, Thakur S, Mayank, Poduri R. Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update. Food Chem Toxicol 2021;151:112106. [PMID: 33722600 DOI: 10.1016/j.fct.2021.112106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Olender SA, Walunas TL, Martinez E, Perez KK, Castagna A, Wang S, Kurbegov D, Goyal P, Ripamonti D, Balani B, De Rosa FG, De Wit S, Kim SW, Diaz G, Bruno R, Mullane KM, Lye DC, Gottlieb RL, Haubrich RH, Chokkalingam AP, Wu G, Diaz-Cuervo H, Brainard DM, Lee IH, Hu H, Lin L, Osinusi AO, Bernardino JI, Boffito M. Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality. Open Forum Infect Dis 2021;8:ofab278. [PMID: 34282406 DOI: 10.1093/ofid/ofab278] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Frediansyah A, Tiwari R, Sharun K, Dhama K, Harapan H. Antivirals for COVID-19: A critical review. Clin Epidemiol Glob Health 2021;9:90-8. [PMID: 33521390 DOI: 10.1016/j.cegh.2020.07.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
43 Meanwatthana J, Majam T. Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection. J Pharm Pract 2021;:8971900211000691. [PMID: 33759631 DOI: 10.1177/08971900211000691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Farhat Ullah M, Ali Y, Ramzan Khan M, Ullah Khan I, Yan B, Ijaz Khan M, Malik MY. A review of COVID-19: Treatment Strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease. Saudi J Biol Sci 2021. [PMID: 34658640 DOI: 10.1016/j.sjbs.2021.10.020] [Reference Citation Analysis]
45 Salton F, Confalonieri P, Meduri GU, Santus P, Harari S, Scala R, Lanini S, Vertui V, Oggionni T, Caminati A, Patruno V, Tamburrini M, Scartabellati A, Parati M, Villani M, Radovanovic D, Tomassetti S, Ravaglia C, Poletti V, Vianello A, Gaccione AT, Guidelli L, Raccanelli R, Lucernoni P, Lacedonia D, Foschino Barbaro MP, Centanni S, Mondoni M, Davì M, Fantin A, Cao X, Torelli L, Zucchetto A, Montico M, Casarin A, Romagnoli M, Gasparini S, Bonifazi M, D'Agaro P, Marcello A, Licastro D, Ruaro B, Volpe MC, Umberger R, Confalonieri M. Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia. Open Forum Infect Dis 2020;7:ofaa421. [PMID: 33072814 DOI: 10.1093/ofid/ofaa421] [Cited by in Crossref: 27] [Cited by in F6Publishing: 37] [Article Influence: 13.5] [Reference Citation Analysis]
46 Govil G, Tomar L, Dhawan P. Evaluation of an asymptomatic COVID-19 patient post-surgery with chest radiography: A surgeon’s dilemma. World J Virol 2021; 10(6): 326-328 [PMID: 34909406 DOI: 10.5501/wjv.v10.i6.326] [Reference Citation Analysis]
47 Hazra S, Chaudhuri AG, Tiwary BK, Chakrabarti N. Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis. Life Sci 2020;257:118096. [PMID: 32679150 DOI: 10.1016/j.lfs.2020.118096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
48 Jamshaid H, Zahid F, Din IU, Zeb A, Choi HG, Khan GM, Din FU. Diagnostic and Treatment Strategies for COVID-19. AAPS PharmSciTech 2020;21:222. [PMID: 32748244 DOI: 10.1208/s12249-020-01756-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
49 Anand K, Vadivalagan C, Joseph JS, Singh SK, Gulati M, Shahbaaz M, Abdellattif MH, Prasher P, Gupta G, Chellappan DK, Dua K. A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics. Chem Biol Interact 2021;344:109497. [PMID: 33991505 DOI: 10.1016/j.cbi.2021.109497] [Reference Citation Analysis]
50 Singh H, Chauhan P, Kakkar AK. Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead. Eur J Pharmacol 2021;890:173717. [PMID: 33152333 DOI: 10.1016/j.ejphar.2020.173717] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
51 Bansal V, Mahapure KS, Bhurwal A, Gupta I, Hassanain S, Makadia J, Madas N, Armaly P, Singh R, Mehra I, O'Horo JC, Kashyap R. Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2020;7:606429. [PMID: 33585508 DOI: 10.3389/fmed.2020.606429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
52 Taboada M, Caruezo V, Naveira A, Atanassoff PG. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease. J Clin Anesth 2020;66:109926. [PMID: 32474331 DOI: 10.1016/j.jclinane.2020.109926] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
53 Rothe K, Feihl S, Schneider J, Wallnöfer F, Wurst M, Lukas M, Treiber M, Lahmer T, Heim M, Dommasch M, Waschulzik B, Zink A, Querbach C, Busch DH, Schmid RM, Schneider G, Spinner CD. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis 2021;40:859-69. [PMID: 33140176 DOI: 10.1007/s10096-020-04063-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
54 Taboada M, Rama P, Pita-Romero R, Moreno E, Leal S, Varela M, Cid M, Caruezo V, Alvarado de la Torre S, Corujeira M, Sarmiento A, Domínguez B, Diaz P, Cánovas L, López Sánchez M, Vilas E, Rodríguez A, Freire L, Domínguez S, Baluja A, Atanassoff PG. Critically ill COVID-19 patients attended by anesthesiologists in northwestern Spain: a multicenter prospective observational study. Rev Esp Anestesiol Reanim (Engl Ed) 2021;68:10-20. [PMID: 33077309 DOI: 10.1016/j.redar.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
55 Kumar V, Kancharla S, Kolli P, Jena M. Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2. F1000Res 2021;10:44. [PMID: 33841800 DOI: 10.12688/f1000research.36371.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Berardi G, Colasanti M, Levi Sandri GB, Del Basso C, Ferretti S, Laurenzi A, Guglielmo N, Meniconi RL, Antonini M, D'Offizi G, Ettorre GM. Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center. Updates Surg 2020;72:281-9. [PMID: 32500431 DOI: 10.1007/s13304-020-00825-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
57 Indini A, Cattaneo M, Ghidini M, Rijavec E, Bareggi C, Galassi B, Gambini D, Ceriani R, Ceriotti F, Berti E, Grossi F. Triage process for the assessment of coronavirus disease 2019-positive patients with cancer: The ONCOVID prospective study. Cancer 2021;127:1091-101. [PMID: 33270908 DOI: 10.1002/cncr.33366] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Amer M, Kamel AM, Bawazeer M, Maghrabi K, Butt A, Dahhan T, Kseibi E, Khurshid SM, Abujazar M, Alghunaim R, Rabee M, Abualkhair M, Al-Janoubi A, AlFirm AT, Gajic O, Walkey AJ, Mosier JM, Zabolotskikh IB, Gavidia OY, Teruel SY, Bernstein MA, Boman K, Kumar VK, Bansal V, Kashyap R; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry. Eur J Med Res 2021;26:117. [PMID: 34600589 DOI: 10.1186/s40001-021-00591-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 De Luca C, Felletti S, Lievore G, Chenet T, Morbidelli M, Sponchioni M, Cavazzini A, Catani M. Modern trends in downstream processing of biotherapeutics through continuous chromatography: The potential of Multicolumn Countercurrent Solvent Gradient Purification. Trends Analyt Chem 2020;132:116051. [PMID: 32994652 DOI: 10.1016/j.trac.2020.116051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
60 Cammalleri V, Muscoli S, Benedetto D, Stifano G, Macrini M, Di Landro A, Di Luozzo M, Marchei M, Mariano EG, Cota L, Sergi D, Bezzeccheri A, Bonanni M, Baluci M, De Vico P, Romeo F. Who Has Seen Patients With ST-Segment-Elevation Myocardial Infarction? First Results From Italian Real-World Coronavirus Disease 2019. J Am Heart Assoc 2020;9:e017126. [PMID: 32901560 DOI: 10.1161/JAHA.120.017126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
61 Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ Open 2020;10:e040129. [PMID: 33028563 DOI: 10.1136/bmjopen-2020-040129] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 20.0] [Reference Citation Analysis]
62 Abd El Hadi SR, Zien El-Deen EE, Bahaa MM, Sadakah AA, Yassin HA. COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach. Drug Des Devel Ther 2021;15:3313-30. [PMID: 34366663 DOI: 10.2147/DDDT.S320320] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Binson G, Venisse N, Sauvaget A, Bacle A, Lazaro P, Dupuis A. Preparation and physicochemical stability of 50 mg/mL hydroxychloroquine oral suspension in SyrSpend SF PH4 (dry). Int J Antimicrob Agents 2020;56:106201. [PMID: 33075513 DOI: 10.1016/j.ijantimicag.2020.106201] [Reference Citation Analysis]
64 Salbach C, Mueller-Hennessen M, Biener M, Stoyanov KM, Vafaie M, Preusch MR, Kihm LP, Merle U, Schnitzler P, Katus HA, Giannitsis E. Validation of two severity scores as predictors for outcome in Coronavirus Disease 2019 (COVID-19). PLoS One 2021;16:e0247488. [PMID: 33606842 DOI: 10.1371/journal.pone.0247488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ferrari M, Paderno A, Giannini L, Cazzador D, Ciardiello C, Carretta G, Piazza C, Nicolai P. COVID-19 screening protocols for preoperative assessment of head and neck cancer patients candidate for elective surgery in the midst of the pandemic: A narrative review with comparison between two Italian institutions. Oral Oncol 2021;112:105043. [PMID: 33129056 DOI: 10.1016/j.oraloncology.2020.105043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Giorli A, Ferretti F, Biagini C, Salerni L, Bindi I, Dasgupta S, Pozza A, Gualtieri G, Gusinu R, Coluccia A, Mandalà M. A Literature Systematic Review with Meta-Analysis of Symptoms Prevalence in Covid-19: the Relevance of Olfactory Symptoms in Infection Not Requiring Hospitalization. Curr Treat Options Neurol 2020;22:36. [PMID: 32874091 DOI: 10.1007/s11940-020-00641-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
67 Alijotas-Reig J, Esteve-Valverde E, Belizna C, Selva-O'Callaghan A, Pardos-Gea J, Quintana A, Mekinian A, Anunciacion-Llunell A, Miró-Mur F. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmun Rev 2020;19:102569. [PMID: 32376394 DOI: 10.1016/j.autrev.2020.102569] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 44.0] [Reference Citation Analysis]
68 Khan A, Cole A, Bhadauria N, El-Hassan M, Abdulla D, Axon T, Fattah Z, Manson JJ, Moreno-Cuesta J, Mukerjee D. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience. Ann Rheum Dis 2020:annrheumdis-2020-218528. [PMID: 32732244 DOI: 10.1136/annrheumdis-2020-218528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Murtas R, Andreano A, Gervasi F, Guido D, Consolazio D, Tunesi S, Andreoni L, Greco MT, Gattoni ME, Sandrini M, Riussi A, Russo AG. Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case-control and population case-control design. Auto Immun Highlights 2020;11:15. [PMID: 33023649 DOI: 10.1186/s13317-020-00141-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
70 Jiménez-Brítez G, Ruiz P, Soler X. [Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience]. Med Clin (Barc) 2020;155:410-1. [PMID: 32718713 DOI: 10.1016/j.medcli.2020.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Koker O, Demirkan FG, Kayaalp G, Cakmak F, Tanatar A, Karadag SG, Sonmez HE, Omeroglu R, Aktay Ayaz N. Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19. Rheumatol Int 2020;40:1613-23. [PMID: 32743705 DOI: 10.1007/s00296-020-04663-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
72 Khan U, Khan AM, Alkatheery N, Khan U. Pandemic and its effect on professional environment on the Kingdom of Saudi Arabia. Environ Sci Pollut Res Int 2021;28:41162-8. [PMID: 33779902 DOI: 10.1007/s11356-021-13501-9] [Reference Citation Analysis]
73 Villar J, Confalonieri M, Pastores SM, Meduri GU. Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019. Crit Care Explor 2020;2:e0111. [PMID: 32426753 DOI: 10.1097/CCE.0000000000000111] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 23.5] [Reference Citation Analysis]
74 Solinas C, Perra L, Aiello M, Migliori E, Petrosillo N. A critical evaluation of glucocorticoids in the management of severe COVID-19. Cytokine Growth Factor Rev 2020;54:8-23. [PMID: 32616381 DOI: 10.1016/j.cytogfr.2020.06.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
75 Kostyra K, Nowak B, Kostkiewicz B. Clipping of a ruptured middle cerebral artery aneurysm in a patient with coronavirus disease 2019 (COVID-19): A case report. Interdiscip Neurosurg 2020;22:100849. [PMID: 32835020 DOI: 10.1016/j.inat.2020.100849] [Reference Citation Analysis]
76 Di Gennaro F, Marotta C, Locantore P, Pizzol D, Putoto G. Malaria and COVID-19: Common and Different Findings. Trop Med Infect Dis 2020;5:E141. [PMID: 32899935 DOI: 10.3390/tropicalmed5030141] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
77 Gbinigie K, Frie K. Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review. BJGP Open 2020;4:bjgpopen20X101069. [PMID: 32265182 DOI: 10.3399/bjgpopen20X101069] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 22.0] [Reference Citation Analysis]
78 Coerdt KM, Khachemoune A. Corona viruses: reaching far beyond the common cold. Afr Health Sci 2021;21:207-13. [PMID: 34394299 DOI: 10.4314/ahs.v21i1.27] [Reference Citation Analysis]
79 Dal Moro F, Livi U. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology. Clin Immunol 2020;214:108414. [PMID: 32272196 DOI: 10.1016/j.clim.2020.108414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
80 Arapović J, Skočibušić S. The first two months of the COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience. Bosn J Basic Med Sci 2020;20:396-400. [PMID: 32464084 DOI: 10.17305/bjbms.2020.4838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
81 Soto A, Quiñones-Laveriano DM, Valdivia F, Juscamayta-López E, Azañero-Haro J, Chambi L, Horna H, Patiño G, Guzman E, De la Cruz-Vargas JA. Detection of Viral and Bacterial Respiratory Pathogens Identified by Molecular Methods in COVID-19 Hospitalized Patients and Its Impact on Mortality and Unfavorable Outcomes. Infect Drug Resist 2021;14:2795-807. [PMID: 34321896 DOI: 10.2147/IDR.S306439] [Reference Citation Analysis]
82 Inchingolo AD, Dipalma G, Inchingolo AM, Malcangi G, Santacroce L, D'Oria MT, Isacco CG, Bordea IR, Candrea S, Scarano A, Morandi B, Del Fabbro M, Farronato M, Tartaglia GM, Balzanelli MG, Ballini A, Nucci L, Lorusso F, Taschieri S, Inchingolo F. The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants. Antioxidants (Basel) 2021;10:881. [PMID: 34072708 DOI: 10.3390/antiox10060881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Xie J, Wang Z, Liang J, Lin H, Yang Z, Wang Y, Liang H, Wu H, Chen R, Ou Y, Wang F, Wang Y, Wang Y, Luo W, Zhang J, Li N, Li Z, Jiang M, Li S, Li J. Critical Review of the Scientific Evidence and Recommendations in COVID-19 Management Guidelines. Open Forum Infect Dis 2021;8:ofab376. [PMID: 34395712 DOI: 10.1093/ofid/ofab376] [Reference Citation Analysis]
84 Smail SW, Saeed M, Twana Alkasalias, Khudhur ZO, Younus DA, Rajab MF, Abdulahad WH, Hussain HI, Niaz K, Safdar M. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review. Food Chem Toxicol 2021;150:112087. [PMID: 33640537 DOI: 10.1016/j.fct.2021.112087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Frater JL, Zini G, d'Onofrio G, Rogers HJ. COVID-19 and the clinical hematology laboratory. Int J Lab Hematol. 2020;42 Suppl 1:11-18. [PMID: 32311826 DOI: 10.1111/ijlh.13229] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 37.5] [Reference Citation Analysis]
86 Spolverato G, Capelli G, Restivo A, Bao QR, Pucciarelli S, Pawlik TM, Gronchi A. The management of surgical patients during the coronavirus disease 2019 (COVID-19) pandemic. Surgery 2020;168:4-10. [PMID: 32451162 DOI: 10.1016/j.surg.2020.04.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
87 Yuce M, Cicek E, Inan T, Dag AB, Kurkcuoglu O, Sungur FA. Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease. Proteins 2021. [PMID: 34169568 DOI: 10.1002/prot.26164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, Fenollar F, Leone M, La Scola B, Devaux C, Gaubert JY, Mege JL, Vitte J, Melenotte C, Rolain JM, Parola P, Lagier JC, Brouqui P, Raoult D. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol 2020;16:1159-84. [PMID: 33356661 DOI: 10.1080/1744666X.2021.1847640] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
89 Russano M, Citarella F, Napolitano A, Dell'Aquila E, Cortellini A, Pantano F, Vincenzi B, Tonini G, Santini D. COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management. Expert Opin Biol Ther. 2020;20:959-964. [PMID: 32588674 DOI: 10.1080/14712598.2020.1789097] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]